Novartis Books Indian Patent for Skin Cancer Drug ‘Tafinlar’ - 21.09.2016

Novartis AG has secured an Indian patent for its skin cancer drug Tafinlar, used in treatment of metastatic melanoma- the most serious and life-threatening type of skin cancer that is associated with low survival rates.

Tags : Novartis Patent Tafinlar

Share :